Gilead Sciences (GILD) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to ...

While Gilead Sciences posted a strong Q2 earnings print, GILD stock saw profit-taking. Here's why the red ink could be an ...

Gilead Sciences delivered a breakout performance Friday, surging 8.3% to $119.41 in its strongest single-day gain in nearly three years on the back of a well received earnings reaction. The rally ...

Gilead Sciences is accelerating its growth rate and Yeztugo might be another major blockbuster. GILD stock is still trading below its intrinsic value. See more.

The article 1 Amazing Chart Shows Why Gilead Sciences, Inc.'s Stock Still Belongs in Your Portfolio originally appeared on Fool.com.

Gilead: Growth Constraints Lead To Rating Downgrade Following 50% Rally Mar. 16, 2025 5:43 PM ET Gilead Sciences, Inc. (GILD) Stock GILD 4 Comments Stephen Ayers 8.73K Follower s Play (9min) ...

Gilead Sciences (NASDAQ: GILD) didn't have a bad first quarter, but investors didn't find it inspiring either. After publishing its earnings report after market close Thursday, the company saw its ...

At Stock Options Channel, our YieldBoost formula has looked up and down the GILD options chain for the new July 18th contracts and identified one put and one call contract of particular interest.

June 20, 2025 — 10:34 am EDT Written by BNK Invest for BNK Invest -> Investors in Gilead Sciences Inc (Symbol: GILD) saw new options begin trading this week, for the February 2026 expiration.